ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P951. A total of 3 filers reported holding ASCENDIS PHARMA A S in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | -66.4% | 3,400 | -67.9% | 0.00% | -100.0% |
| Q2 2023 | $946 | -29.4% | 10,600 | -15.2% | 0.00% | 0.0% |
| Q1 2023 | $1,340 | +21.9% | 12,500 | +38.9% | 0.00% | 0.0% |
| Q4 2022 | $1,099 | -99.7% | 9,000 | +150.0% | 0.00% | – |
| Q2 2022 | $334,000 | -69.0% | 3,600 | -60.9% | 0.00% | -100.0% |
| Q1 2022 | $1,079,000 | +634.0% | 9,200 | +736.4% | 0.00% | – |
| Q4 2021 | $147,000 | -63.5% | 1,100 | -63.3% | 0.00% | – |
| Q3 2021 | $403,000 | +2.3% | 3,000 | 0.0% | 0.00% | – |
| Q2 2021 | $394,000 | +39.2% | 3,000 | +13536.4% | 0.00% | -100.0% |
| Q1 2021 | $283,000 | +1668.8% | 22 | +2100.0% | 0.00% | – |
| Q4 2020 | $16,000 | -65.2% | 1 | -66.7% | 0.00% | – |
| Q3 2020 | $46,000 | -97.5% | 3 | -98.1% | 0.00% | -100.0% |
| Q1 2020 | $1,824,000 | +4348.8% | 162 | +5300.0% | 0.00% | – |
| Q4 2019 | $41,000 | -84.8% | 3 | -89.3% | 0.00% | -100.0% |
| Q3 2019 | $269,000 | -91.7% | 28 | -90.0% | 0.00% | -88.9% |
| Q2 2019 | $3,224,000 | +10.5% | 280 | +12.9% | 0.01% | +12.5% |
| Q1 2019 | $2,918,000 | +294.9% | 248 | +110.2% | 0.01% | +300.0% |
| Q4 2018 | $739,000 | +108.8% | 118 | +136.0% | 0.00% | +100.0% |
| Q3 2018 | $354,000 | +6.6% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $332,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 36,800 | $3,421,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 7,500 | $697,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,600 | $334,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |